DNM2 and cancer: In previously reported experimental systems, cells transformed with a single agent can be reverted by the introduction of TM1 alone (Prasad et al, 1993, 1999); therefore, it is possible that the multistep mutations that cause human cancer mean that replacing a single cytoskeletal protein will be insufficient to restore normal function in many cancers.